Vesicles Secreted by Renal Cell Carcinoma Cells Cause Vascular Endothelial Cells to Express PSMA and Drive Tumor Progression
Open Access
Abstract
Prostate-specific membrane antigen (PSMA) protein expression is induced during prostate cancer progression and metastasis. Recently, we reported that PSMA-positive vesicles released by prostate cancer cell lines enhanced vascular endothelial cell angiogenesis and that PSMA may be involved in tumor angiogenesis. Similarly, it is known that PSMA is upregulated in peritumoral vessels in renal cell carcinoma (RCC). In this study, we investigated the significance and molecular function of PSMA in RCC. PSMA immunohistochemical staining confirmed PSMA presence only in perinephric tumor vessels, and PSMA intensity was strongly correlated with recurrence rate and venous invasion. Spatial gene expression analysis revealed that FOLH1 expression, which codes PSMA, was upregulated in tumor blood vessels around renal cancer, and that angiogenesis-related pathways were enhanced. The 10,000 g pellet fraction of the renal cancer cell lines Caki1- and ACHN-conditioned medium (CM) induced PSMA positivity in human umbilical vein endothelial cells (HUVECs) and enhanced tube formation. Mass spectrometry indicated that the 10,000 g pellet fraction contained various kinds of growth factors, like GDF15 and MYDGF. RNA sequencing showed that supplementing HUVECs with RCC cell CM-enhanced angiogenesis-related signaling pathways. Conclusively, microvesicle components secreted by RCC cells transform vascular endothelial cells into PSMA-positive cells, enhancing angiogenesis.Keywords
Funding Information
- Suzuki Urological Research Funding Foundation (22K09529, 21K09427)
- JSPS KAKENHI (22K09529, 21K09427)
- Takahashi Industrial and Economic Research Foundation (22K09529, 21K09427)
This publication has 45 references indexed in Scilit:
- PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0European Journal of Nuclear Medicine and Molecular Imaging, 2023
- Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectivesJournal of Cancer Research and Clinical Oncology, 2022
- Bivalent-histone-marked immediate-early gene regulation is vital for VEGF-responsive angiogenesisCell Reports, 2022
- PSMA‐positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic stateThe Prostate, 2021
- Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CTAnnals of Nuclear Medicine, 2019
- SNX9 determines the surface levels of integrin β1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9Journal of Cellular Physiology, 2019
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018European Journal of Cancer, 2018
- Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastasesClinical & Experimental Metastasis, 2017
- A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety updateEuropean Journal of Cancer, 2013
- A comparison of fertilization envelope development in three species of Strongylocentrotus (S. Franciscanus, S. Droebachiensis, and S. purpuratus)Molecular Reproduction and Development, 1990